Document is current
Any future updates will be listed below
-
Authors
Rácz, Anita https://orcid.org/0000-0001-8271-9841
Mihalovits, Levente M. https://orcid.org/0000-0003-1022-3294
Beckers, Maximilian https://orcid.org/0000-0001-5988-1322
Fechner, Nikolas https://orcid.org/0000-0003-3852-3950
Stiefl, Nikolaus https://orcid.org/0000-0003-2562-7080
Sirockin, Finton
McCoull, William https://orcid.org/0000-0002-2977-1744
Evertsson, Emma
Lemurell, Malin https://orcid.org/0000-0001-8718-9421
Makara, Gergely
Keserű, György M. https://orcid.org/0000-0003-1039-7809
- License Information
-
More Information
Article History
Accepted: 9 May 2025
First Online: 7 July 2025
Competing interests
: M.B., N.F., F.S. and N.S. are or were employees and shareholders of Novartis Pharma. W.M., E.E. and M.L. are employees and shareholders of AstraZeneca. G.M. is a shareholder of ChemPass. G.M.K. is a scientific advisory board member of Cytocast, ChemPass and Molecure Therapeutics and a shareholder of Gedeon Richter.
